This brand name is authorized in Finland
The drug OBSIDAN FE contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Ferroglycine sulfate complex
UNII JGK960078D - FERROGLYCINE SULFATE
|
|
Ferrous glycine sulfate is a medicinal product for the treatment of iron deficiency. It contains iron (Fe2+) in a form that the body can easily absorb and utilize and is therefore suitable to eliminate symptoms caused by iron deficiency. Like all iron preparations, ferrous glycine sulfate has no effects on erythropoiesis or anaemia that is not due to iron deficiency. |
|
2
Ferrous sulfate heptahydrate
UNII 39R4TAN1VT - FERROUS SULFATE
|
|
Iron sulphate is a co-factor of various enzymes necessary for the transfer of energy (eg. cytochrome oxidase, xanthine oxidase). Iron is also present in hemoglobin and myoglobin, which are essential for the transport and use of oxygen. |
|
3
Aminoacetic acid
UNII TE7660XO1C - GLYCINE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B03AA01 | Ferrous glycine sulfate | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AA Iron bivalent, oral preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 577619 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
